We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Wendy Halpern - Senior Fellow - Pathologist, Safety Assessment Pathology

Wendy Halpern

Senior Fellow - Pathologist, Safety Assessment Pathology

"Committed to serving the underserved, with persistence fueled by curiosity."
Years at Genentech
Publications at Genentech

I joined Genentech as a Scientist/Pathologist in 2007, following seven years at a smaller biotechnology company. I am currently a Staff Scientist/Pathologist in Safety Assessment, supporting several programs from discovery through post-marketing as a team member or leader. Within Safety Assessment, I also lead strategic support of reproductive, developmental and juvenile toxicity across our portfolio, and contribute to strategies in other areas such as safety pharmacology and inhalation toxicology. My broad interests have allowed me to build a strong foundation around drug development and its regulation and implementation. I support and applaud efforts by Roche/Genentech to uphold high standards of science, sustainability, and commitment to the ethics and welfare in support of our medical advances.